Development of a New Building Block for the Synthesis of Silicon-Based Drugs and Odorants: Alternative Synthesis of the Retinoid Agonist Disila-bexarotene

Citations Over TimeTop 10% of 2007 papers

Abstract

With 4,4,5,5-tetramethyl-2-(3,5,5,8,8-pentamethyl-5,8-disila-5,6,7,8-tetrahydro-2-naphthyl)-1,3,2-dioxaborolane (5) a new building block for the synthesis of biologically active 5,8-disila-5,6,7,8-tetrahydronaphthalene derivatives has been made available. The high synthetic potential of 5 has been demonstrated by the development of a new synthesis of the retinoid agonist disila-bexarotene (1).

Related Papers

• → Stressin₁-A, a Potent Corticotropin Releasing Factor Receptor 1 (CRF₁)-Selective Peptide Agonist(2007)42 cited
• → Therapeutic Advances in Cutaneous T-Cell Lymphoma (CTCL): From Retinoids to Rexinoids(2006)19 cited
• → Retinoids(2004)12 cited
• → DESIGN OF TWO STUDIES IN EMPHYSEMA WITH AN ORALLY ACTIVE, GAMMA SELECTIVE RETINOID AGONIST (R667)(2007)1 cited
• → Use of N-ethylmaleimide to directly determine the proportion of β-adrenergic receptors exhibiting high affinity for agonists on human mononuclear leukocyte membranes(1989)1 cited